Author/Authors :
Kanoupakis، نويسنده , , Emmanuel M. and Manios، نويسنده , , Emmanuel G. and Mavrakis، نويسنده , , Hercules E. and Tzerakis، نويسنده , , Panos G. and Mouloudi، نويسنده , , Helen K. and Vardas، نويسنده , , Panos E.، نويسنده ,
Abstract :
Pretreatment with antiarrhythmic agents could improve cardioversion and recurrence rates in patients with persistent atrial fibrillation. In a prospective controlled trial, 145 patients were randomly assigned to treatment with carvedilol, amiodarone, or placebo for 4 weeks before electrical cardioversion. Although the 2 drugs had similar effects on cardioversion rates, amiodarone was superior in terms of sinus rhythm maintenance after conversion.
